Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers

Abstract Background The PLCG2-P522R variant, which encodes a mildly hyperactive form of the PLCγ2 enzyme, has been identified as a protective genetic factor against Alzheimer’s disease (AD). Many recently discovered AD-associated microglial risk genes converge on the TREM2-PLCγ2 signaling pathway, e...

詳細記述

書誌詳細

主要な著者:	Heli Jeskanen, Sami Heikkinen, Inka Kervinen, Jenni Lehtisalo, Tiia Ngandu, Roosa-Maria Willman, Jessica Rosa, Dorit Hoffmann, FinnGen, Ville Leinonen, Annakaisa Haapasalo, Mari Takalo, Henna Martiskainen, Mikko Hiltunen
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2026-01-01
シリーズ:	Alzheimer’s Research & Therapy
主題:	Alzheimer’s Disease PLCG2-P522R PLCG2 Ghrelin TREM2 Onset age
オンライン･アクセス:	https://doi.org/10.1186/s13195-026-01957-1
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!